Groww Logo
Home>US Stocks>Editas Medicine Inc

Editas Medicine Inc

Healthcare
$11.63
+ $0.49 (4.40%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $11.60$11.631,8351,658,771

      Fundamentals

      Market Cap$798.30M
      P/B Ratio1.6
      P/E Ratio-4.3
      Enterprise Value$610.60M
      Div. Yield0.00%
      Book Value7.49
      EPS(TTM)-2.73
      ROE-32.90%
      Understand Fundamentals

      About the Company

      Editas Medicine is a clinical-stage biotechnology firm developing CRISPR–Cas9 gene-editing treatments. Editas is headquartered in Cambridge, Massachusetts, with offices in Boulder, Colorado. Editas was founded in the year 2013 under the name Gengine,
      Editas Medicine is a clinical-stage biotechnology firm developing CRISPR–Cas9 gene-editing treatments. Editas is headquartered in Cambridge, Massachusetts, with offices in Boulder, Colorado. Editas was founded in the year 2013 under the name Gengine, Inc. by Feng Zhang of the Broad Institute, Jennifer Doudna of the University of California, Berkeley, and George Church, David Liu, and J. Keith Joung of Harvard University, with funding from Third Rock Ventures, Polaris Partners, and Flagship Ventures; the name was later changed to the current one. Editas with Allergan was the first to try to alter DNA within a person's body using CRISPR. Editas revised its agreement with Allergan's parent company, AbbVie, and recovered full rights to their portfolio of eye disease treatment medicines, including EDIT-101 for the treatment of LCA10. In Boulder, Colorado, the firm is constructing new chemical facilities.
      ...Read more
      OrganisationEditas Medicine Inc

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on Editas Medicine Inc

      Can I Buy Editas Medicine Inc Shares in India?

      Yes, Editas Medicine Inc shares can be bought in India by opening an international trading account with Groww.

      How to Buy Editas Medicine Inc Shares in India?

      One can easily invest in Editas Medicine Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Editas Medicine Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Editas Medicine Inc.

      What is the Share Price of Editas Medicine Inc?

      The share price of Editas Medicine Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Editas Medicine Inc share price is $11.63 as of 17 May ‘22

      What is the Market Cap of Editas Medicine Inc?

      The Editas Medicine Inc market cap is $798.30M as of 17 May ‘22

      What is the PE and PB ratio of Editas Medicine Inc?

      The PE and PB ratio of Editas Medicine Inc is -4.3 and 1.6 as of 17 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.3.8
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW